Table II.
Clinical characteristics of 11 patients with CRC.
| Patient no. | Sex | Age at surgery (years) | Histology | TNM | Tumor stage | Size of tumor tissue (cm) | Maximum diameter (cm) | Adjuvant chemotherapy at surgery | Family history of cancer |
|---|---|---|---|---|---|---|---|---|---|
| H1001 | Male | 69 | Colon | T4bN0M0 | IIC | 4.0×3.0×2.0 | 4.0 | N | N |
| H1002 | Female | 50 | Colon | T2N1aM0 | IIIA | 2.1×1.5×0.6 | 2.1 | Oxaliplatin+5-FU (20 weeks) | N |
| H1003 | Male | 73 | Rectum | T3N2aM1b | IVB | 5.5×4.0×0.8 | 5.5 | Capecitabine (10 weeks) | Y |
| H1004 | Female | 49 | Rectum | T2N0M0 | I | 2.0×2.0×0.5 | 2.0 | Oxaliplatin+5-FU (2 weeks) | N |
| Capecitabine (12 weeks) | |||||||||
| H1005 | Female | 60 | Colon | T3N1cM0 | IIIB | 2.2×1.8×1.0 | 2.2 | Oxaliplatin (16 weeks) | NA |
| H1006 | Female | 69 | Colon | T1N0M0 | I | 1.5×1.5×1.0 | 1.5 | N | Y |
| H1007 | Male | 53 | Colon | T2N0M0 | I | 4.3×2.5×1.2 | 4.3 | Oxaliplatin+5-FU (4 weeks) | N |
| Capecitabine (18 weeks) | |||||||||
| H1008 | Female | 61 | Colon | T1N0M0 | I | 7.5×4.0×3.5 | 7.5 | Capecitabine (18 weeks) | N |
| H1009 | Male | 67 | Colon | T3N0M0 | IIA | 11.0×4.0×1.2 | 11 | Capecitabine (18 weeks) | N |
| H010 | Female | 35 | Colon | T3N1aM0 | IIIB | 3.0×2.5×0.7 | 3 | Oxaliplatin+5-FU (20 weeks) | N |
| H1011 | Female | 48 | Colon | T3N0M0 | IIA | 2.5×4.5×1.5 | 4.5 | Capecitabine (24 weeks) | N |
N, no; Y, yes; TNM, tumor-node metastasis; 5-FU, fluorouracil; NA, unknown.